Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Koninklijke Philips NV ADR is a medical devices business based in the US. Koninklijke Philips NV ADR shares (PHG) are listed on the NYSE and all prices are listed in US Dollars. Koninklijke Philips NV ADR employs 78,831 staff and has a trailing 12-month revenue of around $17.2 billion.
Our top pick for
Beginners
Our top pick for
Free trades
Our top pick for
Social traders
| Latest market close | $15.31 |
|---|---|
| 52-week range | $15.44 - $46.39 |
| 50-day moving average | $18.97 |
| 200-day moving average | $26.89 |
| Wall St. target price | $32.60 |
| PE ratio | 35.9314 |
| Dividend yield | $0.85 (5.75%) |
| Earnings per share (TTM) | $0.43 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $15.31 from 2022-09-28
| 1 week (2022-09-22) | -7.55% |
|---|---|
| 1 month (2022-08-30) | -7.77% |
| 3 months (2022-06-30) | -28.89% |
| 6 months (2022-03-30) | -51.05% |
| 1 year (2021-09-30) | -65.55% |
|---|---|
| 2 years (2020-09-30) | -67.53% |
| 3 years (2019-09-30) | 46.13 |
| 5 years (2017-09-29) | 41.2 |
Valuing Koninklijke Philips NV ADR stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Koninklijke Philips NV ADR's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Koninklijke Philips NV ADR's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 36x. In other words, Koninklijke Philips NV ADR shares trade at around 36x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Koninklijke Philips NV ADR's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.8071. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Koninklijke Philips NV ADR's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Koninklijke Philips NV ADR's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.3 billion.
The EBITDA is a measure of a Koninklijke Philips NV ADR's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $17.2 billion |
|---|---|
| Operating margin TTM | 3.73% |
| Gross profit TTM | $7.2 billion |
| Return on assets TTM | 1.3% |
| Return on equity TTM | 3.03% |
| Profit margin | 17.19% |
| Book value | $16.64 |
| Market capitalisation | $14.4 billion |
TTM: trailing 12 months
Dividend payout ratio: 86.07% of net profits
Recently Koninklijke Philips NV ADR has paid out, on average, around 86.07% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 5.75% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Koninklijke Philips NV ADR shareholders could enjoy a 5.75% return on their shares, in the form of dividend payments. In Koninklijke Philips NV ADR's case, that would currently equate to about $0.85 per share.
Koninklijke Philips NV ADR's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
Koninklijke Philips NV ADR's most recent dividend payout was on 7 June 2022. The latest dividend was paid out to all shareholders who bought their shares by 11 May 2022 (the "ex-dividend date").
Koninklijke Philips NV ADR's shares were split on a 4:1 basis on 17 April 2000. So if you had owned 1 share the day before before the split, the next day you'd have owned 4 shares. This wouldn't directly have changed the overall worth of your Koninklijke Philips NV ADR shares – just the quantity. However, indirectly, the new 75% lower share price could have impacted the market appetite for Koninklijke Philips NV ADR shares which in turn could have impacted Koninklijke Philips NV ADR's share price.
Over the last 12 months, Koninklijke Philips NV ADR's shares have ranged in value from as little as $15.44 up to $46.3933. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Koninklijke Philips NV ADR's is 0.9058. This would suggest that Koninklijke Philips NV ADR's shares are less volatile than average (for this exchange).
Koninklijke Philips N. V. operates as a health technology company in North America and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, includes magnetic resonance imaging, computed tomography (CT) systems, X-ray systems, and detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; integrated interventional systems; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. It also offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. In addition, the company provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding and digital parental solutions; and male grooming and beauty products and solutions.
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
A simple guide to buying stocks in your favorite European soccer team.
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.